Supplementary Figure 6 from Nottingham Clinico-Pathological Response Index (NPRI) after Neoadjuvant Chemotherapy (Neo-ACT) Accurately Predicts Clinical Outcome in Locally Advanced Breast Cancer

Supplementary Figure 6. Receiver operating characteristic (ROC) analysis of Nottingham clinico-pathological response index (NPRI) score and other clinico-pathological covariates were performed for predicting disease free survival in the training (A), internal validation (B), external validation (C) and combined three cohorts (D).